Category: snoring and apnea

Solve The Snoring Problem To Save A Loving Relationship 0

Solve The Snoring Problem To Save A Loving Relationship

Why let snoring destroy a loving relationship? It’s totally absurd to let go of the one you love simply because of snoring.

Keep in mind that true love comes only once in a lifetime. Heck, it might not even come at all for some people. So, if it does come to you in the in the form of someone who snores, accept it wholeheartedly. Don’t let snoring break up your loving relationship. Sad to say, that’s a lot easier said than done. Truth be told, snoring can really put a strain in a relationship.

Being in the relationship itself is quite a challenge, but being in a relationship with a snorer is even harder. The same problem every night puts a great strain on the relationship. It disturbs both partners’ sleep. As a result, they feel exhausted during the day.

Snoring also leads to frustration between the couple since partner who can’t sleep well tends to blame a snorer. According to research conducted by Ohio State University, partners who don’t get at least seven hours of sleep tend

New Study Establishes Normative Polysomnographic Values in Healthy Adults 0

New Study Establishes Normative Polysomnographic Values in Healthy Adults

A study recently published in The Lancet produced normative values for sleep data in healthy adults, which may help aid in future research, particularly when obtaining polysomnographic control data is difficult.

Researchers included 5273 participants from 169 studies that were published between 2007 and 2016 in this meta-analysis. These studies included data on polysomnographic parameters collected overnight using recent American Academy of Sleep Medicine scoring criteria.

Any studies including participants with treatments or conditions that might affect sleep were excluded. Pooled estimates of 14 polysomnographic factors constituted the study end points, using a random-effects generic inverse meta-analysis to estimate each factor. Multivariate mixed-effects meta-regressions were used to assess the effects of sex and age.

from Sleep Review http://www.sleepreviewmag.com/2019/05/sleep-data-normative-polysomnographic-data-healthy-adults/…

Mets First Baseman Discovers Sleep Apnea To Blame For Underperformance On The Field 0

Mets First Baseman Discovers Sleep Apnea To Blame For Underperformance On The Field

Dominic Smith was a first round draft pick for the New York Mets a couple of years ago, but the young first baseman turned out to be somewhat of a disappointment, reports CBS New York.

Then Dominic got a clue from his teammates as to what might be the problem.

“People would tell me that I would stop breathing throughout the night when I sleep, my roommates in the minor leagues and stuff like that,” said Smith.

from Sleep Review http://www.sleepreviewmag.com/2019/05/mets-first-baseman-discovers-sleep-apnea-to-blame-for-underperformance-on-the-field/…

Study Affirms Self-reported Sleep Duration as Useful Health Measure in Children 0

Study Affirms Self-reported Sleep Duration as Useful Health Measure in Children

While sleep questionnaires are commonly completed by children and their parents, there has been a lack of data comparing the validity of these self-reported sleep parameters. A new study indicates that these sleep characteristics are relatively accurate compared to one another, and they vary only slightly from objective sleep measures.

selfreportedsleep

Bland-Altman plots comparing child report (blue graph) and parent-report (red graph) of total sleep time. Credit: American Academy of Sleep Medicine. Journal of Clinical Sleep Medicine volume 15, issue number 1

Results show that when compared with objective sleep characteristics recorded during overnight polysomnography, there was strong agreement between both child report and parent report: Children overestimated their sleep duration by a median of 32 minutes, and parents overestimated their child’s sleep duration by 36 minutes. Similarly, children overestimated the time it took them to fall asleep—known as “sleep latency”- by four minutes, and parents overestimated their child’s sleep latency by two minutes.

According to the authors, similar variances have been found in previous studies that used actigraphy to estimate sleep parameters in comparison with overnight polysomnography. In prior research,

9 Emerging Devices That Will Disrupt Health Care 0

9 Emerging Devices That Will Disrupt Health Care

Israel 21c predicts that’s Nyxoah’s leadless and minimally invasive neurostimulator for treating sleep apnea will disrupt healthcare.

The company is now gathering additional clinical evidence on Genio, initiating European market development and working toward FDA approval.

OSA is the most common form of sleep apnea, a condition estimated to affect at least 100 million people worldwide.

from Sleep Review http://www.sleepreviewmag.com/2019/05/9-emerging-devices-disrupt-health-care/…

Male Infertility Linked to Being Overweight, Sleep Apnea 0

Male Infertility Linked to Being Overweight, Sleep Apnea

Adrienne Gentry, Carilion reproductive endocrinology and infertility specialist, says she has seen sperm counts improve for some men a few months after starting CPAP, reports WSLS.

“Here, I’ve seen more and more male factor and I think it’s associated with men who are overweight or who have sleep apnea that hasn’t been diagnosed and treated. It’s crazy that treatment with a CPAP for two or three months completely improves their sperm to normal,” said Dr. Gentry.

from Sleep Review http://www.sleepreviewmag.com/2019/05/male-infertility-linked-to-being-overweight-sleep-apnea/…

Cardiovascular Complications Risk Post-surgery Doubles for Those with Sleep Apnea 0

Cardiovascular Complications Risk Post-surgery Doubles for Those with Sleep Apnea

Patients who have severe obstructive sleep apnea have a significantly higher risk of complications related to their heart in the first 30 days after major surgery. This is according to a new study published in The Journal of the American Medical Association (JAMA).

“We found that the risk of postoperative complications related to their heart was 50% higher in patients with sleep apnea compared to those without sleep apnea,” says Frances Chung, MBBS, FRCPC, a clinician investigator with the Krembil Research Institute and a professor in the department of anesthesiology and pain management at the University Health Network and University of Toronto, in a release.

During obstructive sleep apnea, the upper airway is blocked by the tongue and surrounding tissues during sleep, which may result in a lack of oxygen to the brain. “As a result, in the general population, obstructive sleep apnea is associated with a higher risk of cardiovascular complications including high blood pressure, angina, irregular heartbeat, heart failure, and sudden death,” says Chung. “In this study, we wanted to determine whether sleep apnea would pose a

Low-flow PAP System Partners with Software Platform to Add Cloud Connectivity, Develop Patient App 0

Low-flow PAP System Partners with Software Platform to Add Cloud Connectivity, Develop Patient App

FRESCA Medical, which makes a low-flow positive airway pressure system for obstructive sleep apnea that expects to launch in the United States in 2020, and Galen Data have partnered to provide cloud connectivity and development of FRESCA’s patient mobile app.

The partnership will leverage the Galen Data cloud platform solution with FRESCA Medical’s PAP system, which has patented SmartValve technology that enables the system to treat sleep apnea with less airflow than conventional CPAP systems. Working together, Galen and FRESCA will launch a cloud-connected sleep platform with features for patients and providers.

“FRESCA Medical is committed to developing effective for sleep apnea sufferers who do not want or cannot tolerate the currently available therapies,” says John Cox, president and CEO of FRESCA Medical, in a release. “CPAP is effective, but is plagued by patient dissatisfaction and treatment abandonment. Quality sleep is fundamental to good health, and new treatment options are urgently needed in our healthcare armamentarium. The medical device market is already one of the largest applications for cloud-based patient monitoring and engagement. The goal of this partnership is to

AirAvant Medical Bongo Rx Now Available for Mild to Moderate Obstructive Sleep Apnea 0

AirAvant Medical Bongo Rx Now Available for Mild to Moderate Obstructive Sleep Apnea

AirAvant Medical’s flagship product Bongo Rx is now available for patients requiring treatment of mild to moderate obstructive sleep apnea (OSA). Bongo Rx is an FDA 510(k) cleared prescription only device that seals in the user’s nose and works by creating back pressure during exhalation. It doesn’t require CPAP hoses or headgear or electricity.

Prescriptions for Bongo Rx may be sent to any provider who can receive and fill a prescription for durable medical equipment (DME) supplies. This includes sleep centers that stock the device as a retail product. It not currently covered under reimbursement, though patients can get reimbursed through health savings accounts and flexible savings accounts with a copy of the receipt and prescription, according to AirAvant.

Sample prescription forms are available online in the patient and provider forms section of AirAvant’s website or the referring physician can write an Rx on their own forms and send it with the patient to access from internet providers or send it to a local DME provider.

“We recognize that people need to have the ability to treat their sleep apnea

Jazz Pharmaceuticals Data to Showcase Ongoing Sleep Medicine Research at SLEEP 2019 0

Jazz Pharmaceuticals Data to Showcase Ongoing Sleep Medicine Research at SLEEP 2019

Fourteen abstracts sponsored by Jazz Pharmaceuticals and one abstract from an investigator-sponsored trial focusing on sodium oxybate will be presented at SLEEP 2019 San Antonio from June 8-12, 2019.

“Jazz is committed to making meaningful strides in researching medicines that can improve the lives of people living with sleep disorders,” says Jed Black, MD, senior vice president, Sleep and CNS Medicine at Jazz Pharmaceuticals and adjunct professor, Stanford University Medical Center, Stanford Center for Sleep Sciences and Medicine, in a release. “There continue to be large unmet needs in these patient populations, and we are looking forward to presenting new data from our sleep portfolio, including our newest sleep medicine to be approved by FDA, solriamfetol.”

On March 20, 2019, Jazz announced that the US Food and Drug Administration (FDA) approved Sunosi (solriamfetol) to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). Sunosi is expected to be commercially available in the United States following the final scheduling decision by the U.S. Drug Enforcement Administration (DEA), which is typically within 90 days